Heart Disease Trial, Recruiting NCT06724653 Sponsor: Chungnam National University Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06724653
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose first heart ultrasound showed the heart pumping at less than 40% of its normal capacity (a measurement called ejection fraction)
  • People whose follow-up heart ultrasound showed the heart pumping at more than 50% of its normal capacity, with the heart's left chamber back to a normal size
  • People whose blood levels of a heart stress marker (NTproBNP) fall below certain limits, which vary depending on how well the kidneys are working — the trial site can confirm which limit applies in each individual case
  • People who are currently taking more than 3 heart failure medications from specific groups (a RAS blocker, a beta blocker, a mineralocorticoid receptor antagonist, and an SGLT-2 inhibitor)

Who may not be able to join:

  • People under 18 years of age
  • People with uncontrolled blood pressure (above 150/90)
  • People who had a procedure to open or bypass blocked heart arteries within the last 6 months
  • People with significant problems with their heart valves
  • People with an irregular heart rhythm that requires medication to control the heart rate
  • People with chronic kidney disease who also have higher-than-normal levels of protein in their urine (above 30mg/g) (confirm with trial site)
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 821043311245

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chungnam National University Hospital
Registry
ClinicalTrials.gov
Start date
6 March 2025
Est. completion
26 May 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Heart failure relapse

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov